Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Mol Cell Neurosci ; 37(2): 359-66, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18326085

ABSTRACT

Macrophages are critically involved in the pathogenesis of genetically caused demyelination, as it occurs in models for inherited demyelinating neuropathies. It is presently unknown which factors link the Schwann cell-based myelin mutation to the activation of endoneurial macrophages. Here we identified the chemokine monocyte chemoattractant protein-1 (MCP-1) as a first and crucial factor upregulated in Schwann cells of mice heterozygously deficient for the myelin protein zero. The chemokine could be identified as an important mediator of macrophage immigration into peripheral nerves. Furthermore, a 50% reduction of chemokine expression by crossbreeding with MCP-1-deficient mice reduced the increase in macrophage numbers in the mutant nerves and lead to a robust amelioration of pathology. Surprisingly, the complete absence of MCP-1 aggravated the disease. Our findings show that reducing but not eliminating chemokine expression can rescue genetically caused demyelination that may be an interesting target in treating demyelinating diseases of the peripheral nervous system.


Subject(s)
Chemokine CCL2/genetics , Macrophages/immunology , Peripheral Nerves/immunology , Peripheral Nervous System Diseases/genetics , Peripheral Nervous System Diseases/immunology , Schwann Cells/immunology , Animals , Chemokine CCL2/immunology , Chemokine CCL2/metabolism , Chemokines/genetics , Chemokines/immunology , Chemokines/metabolism , Chemotaxis, Leukocyte/genetics , Disease Models, Animal , Macrophages/metabolism , Mice , Mice, Knockout , Mice, Transgenic , Myelin P0 Protein/genetics , Myelin Sheath/immunology , Myelin Sheath/metabolism , Myelin Sheath/pathology , Nerve Fibers, Myelinated/immunology , Nerve Fibers, Myelinated/metabolism , Nerve Fibers, Myelinated/pathology , Peripheral Nerves/metabolism , Peripheral Nerves/physiopathology , Peripheral Nervous System Diseases/physiopathology , Polyradiculoneuropathy/genetics , Polyradiculoneuropathy/immunology , Polyradiculoneuropathy/physiopathology , Schwann Cells/metabolism
2.
Mol Cell Neurosci ; 35(1): 153-60, 2007 May.
Article in English | MEDLINE | ID: mdl-17383197

ABSTRACT

Mice homozygously deficient for the myelin component P0 show loss of axons in peripheral nerves. In order to investigate the morphological characteristics of degenerating axons, we crossbred the myelin mutants with a transgenic mouse line expressing yellow fluorescent protein (YFP) in a small proportion of neurons. Peripheral nerves of the double mutants were prepared into small fiber bundles and investigated by fluorescence microscopy. We could identify the tips of degenerating axon as bulb-like structures. Additionally, by electron microscopy, these structures were characterized as axoplasmic extensions containing numerous membraneous compartments. By immunoelectron microscopy, the degenerating end bulbs were in contact with ensheathing Schwann cells that contained YFP-immunoreactivity possibly reflecting phagocytosis of axon material by these cells. Immunohistochemistry using antibodies against macrophages revealed that YFP-positive bulbs, but also other axonal swellings, were often associated with macrophages supporting our previous findings that myelin-related axonal loss is partially mediated by these cells.


Subject(s)
Axons/pathology , Luminescent Proteins/genetics , Nerve Degeneration/pathology , Nerve Degeneration/physiopathology , Schwann Cells/pathology , Animals , Axons/physiology , Axons/ultrastructure , Luminescent Proteins/metabolism , Macrophages/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Fluorescence , Microscopy, Immunoelectron , Myelin P0 Protein/genetics , Phagocytosis/physiology , Quadriceps Muscle/innervation , Schwann Cells/physiology , Schwann Cells/ultrastructure , Sciatic Nerve/pathology , Sciatic Nerve/physiopathology , Tibial Nerve/pathology , Tibial Nerve/physiopathology
3.
Exp Neurol ; 203(1): 55-62, 2007 Jan.
Article in English | MEDLINE | ID: mdl-16962581

ABSTRACT

Mouse mutants heterozygously deficient for the myelin protein P0 (P0+/-) resemble certain forms of human hereditary neuropathies. Endoneurial macrophages of intrinsic origin are intimately involved in the pathogenesis of the demyelinating neuropathy in these mutants. We have previously shown that deficiency for macrophage colony stimulating factor (M-CSF) prevents an increase of the number of endoneurial macrophages and alleviates the mutants' demyelinating phenotype. The aim of this study was to investigate which population of endoneurial macrophages - long-term resident macrophages or recently infiltrated macrophages - is affected by M-CSF deficiency. For this purpose, we generated bone marrow chimeric mice by transplanting GFP+ bone marrow into P0 mutants (P0+/-) and P0 mutants that lack M-CSF (P0+/- mcsf-op). This enabled us to discriminate recently infiltrated short-term resident GFP+ macrophages from long-term resident GFP- macrophages. Three months after bone marrow transplantation, P0+/- mice expressing M-CSF showed a substantial upregulation and activation of both GFP- and GFP+ macrophages in femoral nerves when compared to P0+/+ mice. In contrast, in P0+/- mcsf-op mutants, both GFP- and GFP+ macrophages did not substantially increase. Only small numbers of GFP+ but no GFP- macrophages were activated and phagocytosed myelin in chimeric P0+/- mcsf-op mutants, possibly reflecting recent activation outside the endoneurium before entering the nerve. Our findings demonstrate that M-CSF is crucial for the activation, in situ increase and myelin phagocytosis of both long-term and short-term resident endoneurial macrophages in P0+/- myelin mutants. M-CSF is, therefore, considered as a target candidate for therapeutic strategies to treat human demyelinating neuropathies.


Subject(s)
Hereditary Sensory and Motor Neuropathy/metabolism , Macrophage Colony-Stimulating Factor/metabolism , Macrophages/metabolism , Myelin P0 Protein/genetics , Peripheral Nerves/metabolism , Polyradiculoneuropathy/metabolism , Animals , Bone Marrow Transplantation , Cell Proliferation , Chemotaxis, Leukocyte/genetics , Chemotaxis, Leukocyte/immunology , Disease Models, Animal , Green Fluorescent Proteins , Hereditary Sensory and Motor Neuropathy/genetics , Hereditary Sensory and Motor Neuropathy/physiopathology , Heterozygote , Mice , Mice, Knockout , Microscopy, Electron, Transmission , Myelin Sheath/immunology , Myelin Sheath/metabolism , Myelin Sheath/ultrastructure , Peripheral Nerves/immunology , Peripheral Nerves/physiopathology , Peripheral Nerves/ultrastructure , Phagocytosis/genetics , Phagocytosis/immunology , Polyradiculoneuropathy/genetics , Polyradiculoneuropathy/physiopathology , Transplantation Chimera , Up-Regulation/physiology
4.
J Neurosci ; 26(31): 8206-16, 2006 Aug 02.
Article in English | MEDLINE | ID: mdl-16885234

ABSTRACT

Overexpression of the major myelin protein of the CNS, proteolipid protein (PLP), leads to late-onset degeneration of myelin and pathological changes in axons. Based on the observation that in white matter tracts of these mutants both CD8+ T-lymphocytes and CD11b+ macrophage-like cells are numerically elevated, we tested the hypothesis that these cells are pathologically involved in the primarily genetically caused neuropathy. Using flow cytometry of mutant brains, CD8+ cells could be identified as activated effector cells, and confocal microscopy revealed a close association of the T-cells with MHC-I+ (major histocompatibility complex class I positive) oligodendrocytes. Crossbreeding the myelin mutants with mice deficient in the recombination activating gene-1 (RAG-1) lacking mature T- and B-lymphocytes led to a reduction of the number of CD11b+ cells and to a substantial alleviation of pathological changes. In accordance with these findings, magnetic resonance imaging revealed less ventricular enlargement in the double mutants, partially because of more preserved corpora callosa. To investigate the role of CD8+ versus CD4+ T-lymphocytes, we reconstituted the myelin-RAG-1 double mutants with bone marrow from either CD8-negative (CD4+) or CD4-negative (CD8+) mice. The severe ventricular enlargement was only found when the double mutants were reconstituted with bone marrow from CD8+ mice, suggesting that the CD8+ lymphocytes play a critical role in the immune-related component of myelin degeneration in the mutants. These findings provide strong evidence that a primary glial damage can cause secondary immune reactions of pathological significance as it has been suggested for some forms of multiple sclerosis and other leukodystrophies.


Subject(s)
Demyelinating Autoimmune Diseases, CNS/immunology , Demyelinating Autoimmune Diseases, CNS/pathology , Lymphocytes/immunology , Lymphocytes/pathology , Myelin Proteolipid Protein/immunology , Nerve Tissue Proteins/immunology , Oligodendroglia/immunology , Oligodendroglia/pathology , Animals , Cells, Cultured , Mice , Mice, Inbred C57BL
5.
Neuromolecular Med ; 8(1-2): 175-90, 2006.
Article in English | MEDLINE | ID: mdl-16775375

ABSTRACT

Mice expressing half of the normal dose of protein zero (P0+/- mice) or completely deficient gap-junction protein connexin 32 -/- mice mimic demyelinating forms of inherited neuropathies, such as Charcot-Marie-Tooth (CMT) neuropathies type 1B and CMT type 1X, respectively. In both models, an almost normal myelin formation is observed during the first months of life, followed by a slowly progressing demyelinating neuropathy. In both models, there is a substantial increase of CD8+ T-lymphocytes and macrophages within the demyelinating nerves. Recently, this has also been observed in mice mildly overexpressing human peripheral myelin protein 22 kD mimicking the most common form of CMT, CMT type 1A. In all demyelinating models, the macrophages show close contacts with intact myelin sheaths or demyelinated axons, suggesting an active role of these cells in myelin degeneration. Additionally, fibroblast-like cells contact macrophages, suggesting a functional role of fibroblast-like cells in macrophage activation. By cross-breeding P0+/- and gap-junction protein connexin 32-/- mice with immunodeficient recombination activating gene-1-deficient mutants, a substantial alleviation of the demyelinating phenotype was observed. Similarly, cross-breeding of P0+/- mice with mutants with a defect in macrophage activation led to an alleviated phenotype as well. These findings demonstrate that the immune system is involved in the pathogenesis of demyelinating neuropathies. In contrast, in P0-/- mice, which display a compromised myelin compaction and axonal loss from onset, immune cells appear to have a neuroprotective effect because cross-breeding with recombination activating gene-1 mutants leads to an aggravation of axonopathic changes. In the present review, we discuss the influence of the immune system on inherited de- and dysmyelination regarding disease mechanisms and possible clinical implications.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Demyelinating Diseases/genetics , Demyelinating Diseases/immunology , Disease Models, Animal , Macrophages/immunology , Peripheral Nervous System Diseases/genetics , Peripheral Nervous System Diseases/immunology , Animals , CD8-Positive T-Lymphocytes/ultrastructure , Connexins/genetics , Connexins/metabolism , Demyelinating Diseases/pathology , Genes, RAG-1 , Humans , Macrophages/ultrastructure , Mice , Mice, Knockout , Mice, Transgenic , Models, Genetic , Myelin P0 Protein/genetics , Myelin P0 Protein/metabolism , Myelin Proteins/genetics , Myelin Proteins/metabolism , Myelin Sheath/metabolism , Myelin Sheath/pathology , Myelin Sheath/ultrastructure , Peripheral Nervous System Diseases/pathology , Gap Junction beta-1 Protein
6.
J Neurosci Res ; 84(1): 37-46, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16676325

ABSTRACT

Patients with hereditary neuropathies are more susceptible to vincristine (VIN)-induced neuropathy than patients without this comorbidity. The heterozygous P0(+/-) mouse is an animal model of a distinct form of inherited neuropathies. These mice produce only 50% of the major myelin protein protein zero (P0) and display signs of demyelination in motor nerves at 4 months of age. Here we investigated the development of neuropathic signs in P0(+/-) and wild-type (wt) mice after VIN treatment. Neuropathy was induced by daily intraperitoneal injections of VIN (0.5 mg/kg body weight) over 10 days. Behavioral and electrophysiological tests were performed at regular time points. Wt mice developed significant hypersensitivity to heat and mechanical stimuli between days 7 and 38 after the first VIN injection. Surprisingly, P0(+/-) mice did not show sensory or motor signs of neuropathy over the whole testing period. Immunohistochemical analysis showed an increase in macrophage numbers in sciatic nerve sections of wt mice after VIN, whereas P0(+/-) mice had higher baseline levels of macrophages without changes after VIN treatment. Semithin sections revealed a decrease in the number of small-diameter myelinated fibers in the sciatic nerves of wt mice after VIN application, whereas P0(+/-) mice had higher baseline values of this fiber subtype that did not change under treatment. Dorsal root ganglion neurons of both genotypes showed an up-regulation of voltage-gated sodium channel immunoreactivity after VIN application without differences between the genotypes. Thus, the P0(+/-) phenotype seems to be protected against VIN-induced neuropathy. The mechanism of this neuroprotection remains elusive.


Subject(s)
Antineoplastic Agents, Phytogenic/toxicity , Myelin P0 Protein/deficiency , Polyneuropathies/chemically induced , Vincristine/toxicity , Action Potentials/drug effects , Action Potentials/genetics , Animals , Behavior, Animal/drug effects , Electrophysiology/methods , Ganglia, Spinal/cytology , Gene Expression Regulation/drug effects , Hyperalgesia/genetics , Hyperalgesia/physiopathology , Immunohistochemistry/methods , Mice , Mice, Inbred C57BL , Mice, Knockout , NAV1.6 Voltage-Gated Sodium Channel , Nerve Tissue Proteins/metabolism , Neural Conduction/drug effects , Neural Conduction/genetics , Neurons/drug effects , Neurons/metabolism , Pain Measurement/methods , Polyneuropathies/pathology , Polyneuropathies/physiopathology , Psychomotor Performance/drug effects , Psychomotor Performance/physiology , Reaction Time/drug effects , Reaction Time/genetics , Sodium Channels/metabolism , Statistics, Nonparametric
7.
Mol Cell Neurosci ; 31(4): 685-91, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16458537

ABSTRACT

Mouse mutants heterozygously deficient for the myelin component P0 mimic some forms of inherited neuropathies in humans. We have previously shown that both T lymphocytes and macrophages contribute to the demyelinating neuropathy. Both cell types appear to influence each other mutually, i.e., impaired T lymphocyte development in RAG-1-deficient P0 mutants leads to decreased macrophage numbers and retarded macrophage activation causes reduced T lymphocyte numbers in the peripheral nerves of P0(+/-) mice. In the present study, we investigated the possible role of the macrophage-restricted sialic acid-binding Ig-like lectin sialoadhesin (Sn, Siglec-1) in the pathogenesis of inherited demyelination in P0(+/-) mice. We found that most peripheral nerve macrophages express Sn in the mutants. Myelin mutants devoid of Sn show reduced numbers of CD8+ T lymphocytes and macrophages in peripheral nerves and less severe demyelination, resulting in improved nerve conduction properties. Our findings are potentially important in the development of future treatment strategies for inherited demyelinating neuropathies.


Subject(s)
Demyelinating Diseases/physiopathology , Macrophages/metabolism , Membrane Glycoproteins/metabolism , Myelin P0 Protein/metabolism , Myelin Sheath/pathology , Receptors, Immunologic/metabolism , Animals , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/metabolism , Charcot-Marie-Tooth Disease/pathology , Charcot-Marie-Tooth Disease/physiopathology , Demyelinating Diseases/metabolism , Demyelinating Diseases/pathology , Disease Models, Animal , Electrophysiology , Humans , Macrophages/cytology , Membrane Glycoproteins/genetics , Mice , Mice, Knockout , Myelin P0 Protein/genetics , Myelin Sheath/metabolism , Peripheral Nerves/pathology , Peripheral Nerves/physiology , Peripheral Nerves/ultrastructure , Phenotype , Receptors, Immunologic/genetics , Sialic Acid Binding Ig-like Lectin 1
8.
J Neurosci Res ; 81(6): 857-64, 2005 Sep 15.
Article in English | MEDLINE | ID: mdl-16041800

ABSTRACT

Charcot-Marie-Tooth neuropathy type 1A (CMT 1 A) is the most common inherited neuropathy in humans and is mostly caused by a 1.5-Mb tandem duplication of chromosome 17 comprising the gene for the peripheral myelin protein 22-kDa (PMP 22). Although there are numerous studies on the functional role of PMP 22, the mechanisms of myelin degeneration under PMP 22-overexpression conditions have not yet been fully understood. We have shown previously that in mouse mutants hetero- or homozygously deficient for two other myelin components, P0 and C x 32, respectively, immune cells contribute to the demyelinating neuropathy. To test this possibility for PMP 22 overexpression, we investigated a putative mouse model for CMT 1 A, i.e., the mouse strain C 6 1 mildly overexpressing human PMP 22 in peripheral nerves. Electron microscopic and electrophysiologic investigations revealed that this mouse strain develops pathologic features similar to those found in CMT 1 A patients. A novel finding, however, was the upregulation of CD8- and F4/80-positive lymphocytes and macrophages, respectively, in peripheral nerves. The observation that macrophages enter endoneurial tubes of the mutants and obviously phagocytose morphologically normal myelin strongly suggests that the myelin degeneration is mediated at least partially by these phagocytic cells. By gene array technology and quantitative RT-PCR of peripheral nerve homogenates from PMP 22 mutants, monocyte chemoattractant protein-1 (MCP-1; cc l2) could be identified as a putative factor to attract or activate macrophages that attack myelin sheaths in this model of CMT 1 A.


Subject(s)
Charcot-Marie-Tooth Disease/pathology , Macrophages/physiology , Myelin Sheath/pathology , Aging/physiology , Animals , Axons/pathology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/physiology , Chemokine CCL2/biosynthesis , Demyelinating Diseases/pathology , Electrophysiology , Humans , Immunohistochemistry , Mice , Mice, Transgenic , Microscopy, Immunoelectron , Myelin Proteins/genetics , Peripheral Nerves/metabolism , Peripheral Nerves/pathology , RNA/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Sciatic Nerve/metabolism , Up-Regulation
9.
Mol Cell Neurosci ; 28(1): 118-27, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15607947

ABSTRACT

In mouse models of later onset forms of human hereditary demyelinating neuropathies, the immune system plays a crucial pathogenic role. Here, we investigated the influence of immune cells on early onset dysmyelination in mice homozygously deficient of the myelin component P0. In peripheral nerves of P0(-/-) mice, CD8+ T-lymphocytes increased with age. Macrophages peaked at 3 months followed by a substantial decline. They were mainly of hematogenous origin. To evaluate the functional role of immune cells, we cross-bred P0(-/-) mutants with RAG-1-deficient mice. At 3 months, the number of endoneurial macrophages did not differ from the macrophage number of immunocompetent myelin mutants, but the later decline of macrophages was not observed. Quantitative electron microscopy revealed that in plantar nerves of 6-month-old double mutants, significantly more axons had degenerated than in immunocompetent littermates. These data suggest a neuroprotective net effect of T-lymphocytes on axon survival in inherited, early onset dysmyelination.


Subject(s)
Demyelinating Diseases/immunology , Genes, RAG-1/genetics , Immune System/immunology , Peripheral Nervous System Diseases/immunology , Wallerian Degeneration/immunology , Age Factors , Animals , CD8-Positive T-Lymphocytes/immunology , Cell Proliferation , Cell Survival/genetics , Cell Survival/immunology , Chemotaxis, Leukocyte/genetics , Chemotaxis, Leukocyte/immunology , Demyelinating Diseases/genetics , Demyelinating Diseases/physiopathology , Disease Models, Animal , Macrophages/immunology , Mice , Mice, Knockout , Microscopy, Electron, Transmission , Myelin P0 Protein/deficiency , Myelin P0 Protein/genetics , Peripheral Nerves/metabolism , Peripheral Nerves/pathology , Peripheral Nerves/ultrastructure , Peripheral Nervous System Diseases/genetics , Peripheral Nervous System Diseases/physiopathology , Tibial Nerve/metabolism , Tibial Nerve/pathology , Tibial Nerve/ultrastructure , Wallerian Degeneration/genetics , Wallerian Degeneration/physiopathology
10.
Hum Mol Genet ; 13(18): 2031-42, 2004 Sep 15.
Article in English | MEDLINE | ID: mdl-15269181

ABSTRACT

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is caused by recessive mutations of the IGHMBP2 gene. The role of IGHMBP2 (immunoglobulin mu-binding protein 2) in the pathomechanism of motor neuron disease is unknown. We have generated antibodies against Ighmbp2 and showed that low levels of Ighmbp2 immunoreactivity are present in the nucleus of spinal motor neurons and high levels in cell bodies, axons and growth cones. Ighmbp2 protein levels are strongly reduced in neuromuscular degeneration (nmd) mice, the mouse model of SMARD1. Mutant mice show severe motor neuron degeneration before first clinical symptoms become apparent. The loss of motor neuron cell bodies in lumbar spinal cord is followed by axonal degeneration in corresponding nerves such as the femoral quadriceps and sciatic nerve and loss of axon terminals at motor endplates. Motor neuron degeneration and clinical symptoms then slowly progress until the mice die at the age of 3-4 months. In addition, myopathic changes seem to contribute to muscle weakness and especially to respiratory failure, which is characteristic of the disorder in humans. Cultured motor neurons from embryonic nmd mice did not show any abnormality with respect to survival, axonal growth or growth cone size, thus differing from motor neurons derived from, e.g. Smn (survival motor neuron) deficient mice, the model of spinal muscular atrophy (SMA). Our data suggest that the pathomechanism in SMARD1 is clearly distinct from other motor neuron diseases such as classic SMA.


Subject(s)
DNA-Binding Proteins/metabolism , Motor Neurons/pathology , Muscular Atrophy, Spinal/etiology , Muscular Atrophy, Spinal/pathology , Transcription Factors/metabolism , Action Potentials/physiology , Animals , Antibodies/immunology , DNA-Binding Proteins/analysis , DNA-Binding Proteins/genetics , Disease Models, Animal , Electromyography , Humans , Mice , Mice, Neurologic Mutants , Motor Neurons/chemistry , Motor Neurons/metabolism , Muscular Atrophy, Spinal/metabolism , Phenotype , Rotarod Performance Test , Spinal Cord/pathology , Transcription Factors/analysis , Transcription Factors/genetics
11.
J Cell Biol ; 165(4): 565-73, 2004 May 24.
Article in English | MEDLINE | ID: mdl-15148307

ABSTRACT

Mutations in the gene of the peripheral myelin protein zero (P0) give rise to the peripheral neuropathies Charcot-Marie-Tooth type 1B disease (CMT1B), Déjérine-Sottas syndrome, and congenital hypomyelinating neuropathy. To investigate the pathomechanisms of a specific point mutation in the P0 gene, we generated two independent transgenic mouse lines expressing the pathogenic CMT1B missense mutation Ile106Leu (P0sub) under the control of the P0 promoter on a wild-type background. Both P0sub-transgenic mouse lines showed shivering and ultrastructural abnormalities including retarded myelination, onion bulb formation, and dysmyelination seen as aberrantly folded myelin sheaths and tomacula in all nerve fibers. Functionally, the mutation leads to dispersed compound muscle action potentials and severely reduced conduction velocities. Our observations support the view that the Ile106Leu mutation acts by a dominant-negative gain of function and that the P0sub-transgenic mouse represents an animal model for a severe, tomaculous form of CMT1B.


Subject(s)
Charcot-Marie-Tooth Disease/genetics , Charcot-Marie-Tooth Disease/pathology , Myelin P0 Protein/genetics , Myelin Sheath/pathology , Peripheral Nerves/abnormalities , Peripheral Nerves/pathology , Action Potentials/genetics , Amino Acid Sequence/genetics , Amino Acid Substitution , Animals , Charcot-Marie-Tooth Disease/metabolism , Disease Models, Animal , Gene Expression Regulation/genetics , Genes, Dominant , Humans , Mice , Mice, Transgenic , Microscopy, Electron , Movement Disorders/genetics , Movement Disorders/metabolism , Movement Disorders/pathology , Mutation, Missense/genetics , Myelin Sheath/metabolism , Myelin Sheath/ultrastructure , Neural Conduction/genetics , Peripheral Nerves/ultrastructure , Promoter Regions, Genetic/genetics , RNA, Messenger/metabolism
12.
Mol Cell Neurosci ; 23(3): 351-9, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12837620

ABSTRACT

Macrophages have recently been shown to be critically involved in the pathogenesis of genetically determined demyelination in mice heterozygously deficient for P0 (P0(+-)). Since little is known about the origin of these cells, we created chimeric P0(+-) mice by transplanting bone marrow from green fluorescent protein (GFP)-transgenic mice into irradiated P0(+-) mice. When analyzing chimeric P0(+-) mice, we could determine two populations (GFP(+) and GFP(-)) of endoneurial macrophages that became phagocytic for myelin and increased in number. We found that both GFP(-) resident macrophages and GFP(+) macrophages proliferated in peripheral nerves of P0(+-) mice but not in nerves of chimeric or nonchimeric P0(++) mice. These findings demonstrate a so far poorly recognized role of resident endoneurial macrophages in demyelinating neuropathies. Surprisingly, we also found GFP(+) cells that unequivocally showed the morphological characteristics of fibroblasts. These blood-borne fibroblast-like cells express the common hematopoetic stem cell marker CD34 and might comprise another cell type of potential importance for immune regulation in hereditary demyelinating neuropathies.


Subject(s)
Macrophages/pathology , Peripheral Nerves/pathology , Peripheral Nervous System Diseases/pathology , Animals , Bone Marrow Transplantation , Cell Movement/immunology , Disease Models, Animal , Fibroblasts/pathology , Green Fluorescent Proteins , Luminescent Proteins/genetics , Macrophages/immunology , Macrophages/ultrastructure , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Immunoelectron , Myelin Sheath/pathology , Peripheral Nervous System Diseases/immunology , Phagocytosis/immunology , Phenotype , Spinal Nerve Roots/pathology , Spinal Nerve Roots/ultrastructure , Transplantation Chimera
13.
J Anat ; 200(4): 405-14, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12090406

ABSTRACT

Mice heterozygously deficient in the peripheral myelin adhesion molecule P0 (P0+/- mice) are models for some forms of Charcot-Marie-Tooth (CMT) neuropathies. In addition to the characteristic hallmarks of demyelination, elevated numbers of CD8-positive T-lymphocytes and F4/80-positive macrophages are striking features in the nerves of these mice. These immune cells increase in number with age and progress of demyelination, suggesting that they might be functionally related to myelin damage. In order to investigate the pathogenetic role of lymphocytes, the myelin mutants were cross-bred with recombination activating gene 1 (RAG-1)-deficient mice, which lack mature T- and B-lymphocytes. The immunodeficient myelin mutants showed a less severe myelin degeneration. The beneficial effect of lymphocyte-deficiency was reversible, since demyelination worsened in immunodeficient myelin-mutants when reconstituted with bone marrow from wild-type mice. Ultrastructural analysis revealed macrophages in close apposition to myelin and demyelinated axons. We therefore cross-bred the P0+/- mice with spontaneous osteopetrotic (op) mutants deficient in the macrophage colony-stimulating factor (M-CSF), hence displaying impaired macrophage activation. In the corresponding double mutants the numbers of macrophages were not elevated in the peripheral nerves, and the demyelinating phenotype was less severe than in the genuine P0+/- mice, demonstrating that macrophages are also functionally involved in the pathogenesis of genetically mediated demyelination. We also examined other models for inherited neuropathies for a possible involvement of immune cells. We chose mice deficient in the gap junction component connexin 32, a model for the X-linked form of CMT. Similar to P0-deficient mice, T-lymphocytes and macrophages were elevated and macrophages showed a close apposition to degenerating myelin. We conclude that the involvement of T-lymphocytes and macrophages is a common pathogenetic feature in various forms of slowly progressive inherited neuropathies.


Subject(s)
Charcot-Marie-Tooth Disease/genetics , Charcot-Marie-Tooth Disease/immunology , Disease Models, Animal , Immune System/physiology , Myelin Sheath/physiology , Animals , Axons/physiology , Chemokine CCL2/genetics , Gene Deletion , Macrophage Activation/physiology , Macrophage Colony-Stimulating Factor/genetics , Macrophages/physiology , Mice , Mice, Neurologic Mutants , Motor Neurons/physiology , Myelin P0 Protein/genetics , Schwann Cells/physiology , T-Lymphocytes/physiology
14.
Neurosci Lett ; 320(1-2): 17-20, 2002 Mar 01.
Article in English | MEDLINE | ID: mdl-11849753

ABSTRACT

Mice deficient in the gap junction protein connexin 32 (Cx32) develop a slowly progressing demyelinating neuropathy, with enlarged periaxonal collars, abnormal non-compacted myelin domains and axonal sprouts. These mice serve as a model for the X-linked form of inherited demyelinating neuropathies in humans. Based on our previous findings that macrophages are involved in demyelination in other myelin mutants (i.e. mice heterozygously deficient in P0), we considered the possibility that macrophages might be also mediators of demyelination in Cx32-deficient mice. Indeed, we detected an age-related increase in the number of macrophages in demyelinating nerves of Cx32-deficient mice. In addition, immunoelectron microscopy revealed macrophages in an apposition to degenerating myelin reminiscent of a macrophage-mediated demyelinating neuropathy. We conclude that involvement of macrophages might be a widespread phenomenon in genetically-determined demyelination.


Subject(s)
Connexins/deficiency , Gap Junctions/genetics , Macrophages/metabolism , Peripheral Nerves/metabolism , Polyradiculoneuropathy/genetics , Animals , Antigens, Differentiation/metabolism , Axons/metabolism , Axons/pathology , Axons/ultrastructure , Cell Count , Connexins/genetics , Female , Gap Junctions/pathology , Gap Junctions/ultrastructure , Immunohistochemistry , Macrophages/pathology , Macrophages/ultrastructure , Male , Mice , Mice, Knockout , Microscopy, Electron , Myelin P0 Protein/deficiency , Myelin P0 Protein/genetics , Peripheral Nerves/pathology , Peripheral Nerves/ultrastructure , Polyradiculoneuropathy/immunology , Polyradiculoneuropathy/pathology , Schwann Cells/metabolism , Schwann Cells/pathology , Schwann Cells/ultrastructure , Up-Regulation/genetics , Up-Regulation/immunology , Gap Junction beta-1 Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...